Preview

Problems of Particularly Dangerous Infections

Advanced search

Development of Criteria for Probiotic Bacteria Selection for Broadening the Spectrum of Available Anti-Cholera Drugs

https://doi.org/10.21055/0370-1069-2012-4-69-72

Abstract

Studied is the anti-cholera activity of 40 strains from different species of probiotic bacteria according to the main qualitative characteristics, which are determined on the basis of quantitative data. Established are the selection criteria for probiotic bacteria to be used for cholera treatment: antagonistic activity against
V. cholerae – high or moderate, adhesion – only moderate, acid forming activity – high or moderate. The preventive and medical efficiency of 5 selected strains of lactobacilli and 1 strain of bifidobacterium is demonstrated on the experimental model of cholera. Underlined is the prospective use of probiotics as additional preparations of choice against cholera infection.

About the Author

V. D. Kruglikov
Rostov-on-Don Research Anti-Plague Institute
Russian Federation


References

1. Andrusenko I.T., Podosinnikova L.S., Bardykh I.D. [Search for new methods of cholera treatment]. Epidemiol. Infek. Bol. 2007; 5:49–52.

2. Bardykh I.D., Kruglikov V.D., Mazrukho B.L., Ryzhko I.V., Moskvitina E.A., Tsuraeva R.I. et al. [Experimental evaluation of efficacy of Lactobacilli in prophylaxis and treatment of cholera]. Zh. Mikrobiol. Epidemiol. Immunobiol. 2001; 2:68–71.

3. Gaevskaya N.E., Kudryakova T.A., Makedonova L.D., Kachkina G.V., Alieva A.A., Sayamov S.R. [Selection of bateriophages for treatment of experi- mental cholera, caused by classical cholera vibrions]. Sovrem. Naukoemkie Tekhnol. 2004; 3:11–5.

4. Dudina N.A. [Multidrug resistance of strains of Vibrio cholerae El Tor, isolated from people in Russia in 2005]. Klin. Mikrobiol. Antimikrob. Khimioter. 2006; 8(2):16–7.

5. Kravtsov E.G., Ermolaev A.V., Anokhina I.V., Yashina N.V., Chesnokova V.L., Dolin M.V. [Adhesion characteristics of lactobacillus is a criterion of the probiotic choice]. Byul. Eks. Biol. Med. 2008; 145(2):192–5.

6. Kruglikov V.D., Ryzhko I.V., Tsuraeva R.I., Drobotkovskaya N.V., Pushkareva N.D., Bardykh I.D. [Examination of influence of acquired resis- tance to rifampicine on stability of biological properties of Lactobacillus aci- dophilus BKM B–2020 D strain]. Biotekhnologia. 1996; 7:32–5.

7. Mayevskaya M.V. [Application of probiotics in gastroenterology]. Ros. Zh. Gastroenterol. Gepatol. Koloproktol. 2009; 19(6):65–72.

8. [Control methods. Biological and microbiological factors. Pre- registration system for pre-clinical drug safety studies. Selection, control and storage of industrial strains, used in probiotics production. MR 4.2.2602-10. 4.2]. M.; 2010.

9. Sheveleva M.A., Ramenskaya G.V. [Modern concept of the use of various groups of probiotics in antibiotic therapy]. Antibiotik. Chimioter. 2009; 54(3–4):61–8.

10. Yankovsky D.S., Dyment G.S. [Bifidobacteria and lactobacilli as the optimal basis for modern probiotics]. Sovr. Pediatriya. 2006; 10(3):1–10.

11. Boirivant M, Strober W. The mechanism of action of probiotics. Curr. Opin. Gastroenterol. 2007; 23(6):679–92.


Review

For citations:


Kruglikov V.D. Development of Criteria for Probiotic Bacteria Selection for Broadening the Spectrum of Available Anti-Cholera Drugs. Problems of Particularly Dangerous Infections. 2012;(4(114)):69-72. (In Russ.) https://doi.org/10.21055/0370-1069-2012-4-69-72

Views: 645


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 0370-1069 (Print)
ISSN 2658-719X (Online)